+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Cardiac Resynchronization Therapy (CRT) Devices Market - Analysis By Product (CRT-D, CRT-P), End-User By Region, By Country (2022 Edition): Market Insights and Forecast with Impact of COVID-19 (2022-2027)

  • PDF Icon

    Report

  • 160 Pages
  • July 2022
  • Region: Global
  • Azoth Analytics
  • ID: 5640086
UP TO OFF until Dec 31st 2022
The Global Cardiac Resynchronization Therapy (CRT) Devices Market was valued at USD 7.14 Billion in the year 2021 with Americas region leading the regional market share. One of the main factors driving this market is the rising prevalence of cardiovascular diseases (CVDs) that lead to heart failure (HF). Each year, approximately 3.5 million people suffer from HF worldwide fostering the demand for cardiac resynchronization therapy devices. Additionally, factors such as technological advancements in devices, expanding CRT product developments, key company initiatives & investments, sedentary lifestyles and ageing demographics around the world are anticipated to impel the market growth in the forecast period.

The Asia Pacific CRT devices market is predicted to be the hotspot and the most lucrative region for the market participants worldwide. Some of the major factors propelling the growth of the cardiac resynchronization therapy devices market in the Asia Pacific region include a favourable reimbursement scenario in Japan, an ageing population in China, an increase in CVD incidence, an improved healthcare infrastructure, an expanding middle-class population, and rising disposable income levels in India.

The cardiac resynchronization therapy (CRT) devices market experienced a period of a temporary setback in the year 2020 as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19 virus. However, after the initial shock and confusion about COVID-19, companies and governments began taking corrective actions to help the economy and businesses recover. These measures included policy & monetary stimulus, easing of restrictions, conditional exemptions, and other strategic initiatives. This resulted in healthcare activities returning to normal pace towards the end of 2020 with the approval and administration of COVID-19 vaccines across the globe, thereby offering better growth prospects for the cardiac resynchronization therapy devices market during the forecast period.

Scope of the Report:

  • The report presents the analysis of Cardiac Resynchronization Therapy Devices Market for the historical period of 2017-2021 and the forecast period of 2022-2027.
  • The report analyses the Cardiac Resynchronization Therapy Devices Market by value (USD Billion).
  • The report analyses the Cardiac Resynchronization Therapy Devices Market by value (USD Billion).
  • The report analyses the Cardiac Resynchronization Therapy Devices Market by Product Type (CRT-Defibrillator and CRT-Pacemaker).
  • The report analyses the Cardiac Resynchronization Therapy Devices Market by End User (Hospitals, Cardiac Centres and Research & Laboratories).
  • The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Region (Americas, Europe, Asia Pacific, MEA).
  • The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Product and by End User.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, and Major Products & Developments and Mergers & Acquisitions. The companies analysed in the report include Medtronic, Boston Scientific Corp., Abbott Laboratories, Biotronik, MicroPort Scientific Corporation, Medico S.p.A, LivaNova and EBR Systems.

Key Target Audience:

  • Cardiac Resynchronization Therapy Devices Manufacturers & Distributers
  • End Users (Hospitals, Cardiac Centers, Research & Laboratories)
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities
  • Investment Banks and Equity Firms
Frequently Asked Questions about the Global Cardiac Resynchronization Therapy (CRT) Devices Market

What is the estimated value of the Global Cardiac Resynchronization Therapy (CRT) Devices Market?

The Global Cardiac Resynchronization Therapy (CRT) Devices Market was estimated to be valued at $7.6 Billion in 2022.

What is the growth rate of the Global Cardiac Resynchronization Therapy (CRT) Devices Market?

The growth rate of the Global Cardiac Resynchronization Therapy (CRT) Devices Market is 6.8%, with an estimated value of $10.6 Billion by 2027.

What is the forecasted size of the Global Cardiac Resynchronization Therapy (CRT) Devices Market?

The Global Cardiac Resynchronization Therapy (CRT) Devices Market is estimated to be worth $10.6 Billion by 2027.

Table of Contents

1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations3. Cardiac Resynchronization Therapy Devices Market: Product Overview
4. Global Cardiac Resynchronization Therapy Devices Market: An Analysis
4.1. Assessment of Macro Economic Indicators of Global Cardiac Resynchronization Therapy Devices Market
4.2 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Value, 2017-2027
4.3 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Volume, (Million Units), 2017-2027
4.4 Global Cardiac Resynchronization Therapy Devices Market: Growth and Forecast
4.5 Impact of COVID-19 on Global Cardiac Resynchronization Therapy Devices Market
5. Global Cardiac Resynchronization Therapy Devices Market Segmentation, By Product (Value)
5.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By Product
5.2 Competitive Positioning of Cardiac Resynchronization Therapy Devices Market: By Product (2021 & 2027)
5.3 By CRT-Defibrillator, By Value (USD Billion), 2017-2027
5.4 By CRT-Pacemaker, By Value (USD Billion), 2017-2027
6. Global Cardiac Resynchronization Therapy Devices Market Segmentation, By End User (Value)
6.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By End-User
6.2 Competitive Positioning of Global Cardiac Resynchronization Therapy Devices Market, By End-User (2021 & 2027)
6.3 By Hospitals, By value (USD Billion), 2017-2027
6.4 By Cardiac Centers, By Value (USD Billion), 2017-2027
6.5 By Research & Laboratories, By Value (USD Billion), 2017-2027
7. Global Cardiac Resynchronization Therapy Devices Market: Regional Analysis
7.1 Competitive Scenario of Global Cardiac Resynchronization Therapy Devices Market: By Region (2021 & 2027)
8. Americas Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
8.1 Assessment of Macro Economic Indicators of Americas Cardiac Resynchronization Therapy Devices Market
8.2 Americas Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
8.3 Americas Cardiac Resynchronization Therapy Devices Market: Prominent Companies
8.4 Americas Cardiac Resynchronization Therapy Devices Market: Segment Analysis
8.5 Americas Cardiac Resynchronization Therapy Devices Market By Product (CRT-Defibrillator and CRT-Pacemaker)
8.6 Americas Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories)
8.7 Americas Cardiac Resynchronization Therapy Devices Market: Country Analysis
8.8 Market Opportunity Chart of Americas Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
8.9 Competitive Positioning of Americas Cardiac Resynchronization Therapy Devices Market- By Country
8.10 United States Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
8.11 United States Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
8.12 Canada Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
8.13 Canada Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9. Europe Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
9.1 Assessment of Macro Economic Indicators of Asia Pacific Cardiac Resynchronization Therapy Devices Market
9.2 Europe Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
9.3 Europe Cardiac Resynchronization Therapy Devices Market: Prominent Companies
9.4 Europe Cardiac Resynchronization Therapy Devices Market: Segment Analysis
9.5 Europe Cardiac Resynchronization Therapy Devices Market By Product (CRT-Defibrillator and CRT-Pacemaker), By Value, 2017-2027
9.6 Europe Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value, 2017-2027
9.7 Europe Cardiac Resynchronization Therapy Devices Market: Country Analysis
9.8 Market Opportunity Chart of Europe Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
9.9 Competitive Positioning of Europe Cardiac Resynchronization Therapy Devices Market- By Country
9.10 Germany Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.11 Germany Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.12 United Kingdom Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.13 United Kingdom Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.14 France Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.15 France Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.16 Italy Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.17 Italy Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
9.18 Spain Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
9.19 Spain Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
10. Asia Pacific Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
10.1 Assessment of Macro Economic Indicators of Asia Pacific Cardiac Resynchronization Therapy Devices Market
10.2 Asia Pacific Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
10.3 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Prominent Companies
10.4 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Segment Analysis
10.5 Asia Pacific Cardiac Resynchronization Therapy Devices Market By Product, (CRT-Defibrillator and CRT-Pacemaker)
10.6 Asia Pacific Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value
10.7 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Country Analysis
10.8 Market Opportunity Chart of Asia Pacific Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
10.9 Competitive Positioning of Asia Pacific Cardiac Resynchronization Therapy Devices Market- By Country
10.10 China Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
10.11 China Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
10.12 Japan Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
10.13 Japan Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
10.14 India Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
10.15 India Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
11. MEA Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
11.1 Assessment of Macro Economic Indicators of MEA Cardiac Resynchronization Therapy Devices Market
11.2 MEA Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
11.3 MEA Cardiac Resynchronization Therapy Devices Market By Product, (CRT-Defibrillator and CRT-Pacemaker)
11.4 MEA Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value
12. Global Cardiac Resynchronization Therapy Devices Market Dynamics
12.1 Global Cardiac Resynchronization Therapy Devices Market Drivers
12.2 Global Cardiac Resynchronization Therapy Devices Market Restraints
12.3 Global Cardiac Resynchronization Therapy Devices Market Trends
13. Market Attractiveness and Strategic Analysis
13.1 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Product (Year 2027)
13.2 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By End User (Year 2027)
13.3 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Region (Year 2027)
13. Competitive Landscape
13.1 Market Share of global leading companies
13.2 SWOT Analysis- Global Cardiac Resynchronization Therapy Devices Market
14. Global Cardiac Resynchronization Therapy Devices Market: Competitive Landscape
14.1 Market Share of global leading companies
14.2 Recent Developments and Mergers & Acquisitions
14.3 Prominent Companies Worldwide Unit Sales of CRT Devices in FY 2021
15. Company Profiles (Business Description, Financial Analysis, Business Strategy)
15.1 Medtronic PLC
15.2 Boston Scientific
15.3 Abbott Laboratories
15.4 Biotronik
15.5 MicroPort Scientific Corporation
15.6 LivaNova PLC
15.7 Medico S.p.A
15.8 EBR Systems
16. About the Publisher
List of Figures
Figure 1: Global GDP per capita (2018-2020) In USD Thousands
Figure 2: Global Aged Population (Above 65), 2017-21 (% of total Population)
Figure 3: Global Aged Population (Above 65), By Country, 2021 (% of total Population, roundoff)
Figure 4: Global Medical Spending in 2020, By Region, (% of Total)
Figure 5: Global Prevalence of Cardiovascular Diseases, (in million), 2015-2019
Figure 6: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2016-2020 (In %)
Figure 7: Global Expected Healthcare Industry Outlook
Figure 8: Regional Expected Healthcare Industry Growth Rate By Year 2024
Figure 9: Global Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 10: Global Cardiac Resynchronization Therapy Devices Market Size, By Volume (Million Units), 2017-2027
Figure 11: Global Cardiac Resynchronization Therapy Devices Market- By Product Market Share, 2021 & 2027
Figure 12: Global Cardiac Resynchronization Therapy Devices Market- By Product, By CRT-Defibrillator, By Value (USD Billion), 2017-2027
Figure 13: Global Cardiac Resynchronization Therapy Devices Market- By Product, By CRT-Pacemaker, By Value (USD Billion), 2017-2027
Figure 14: Global Cardiac Resynchronization Therapy Devices Market- By End-User Market Share, 2021 & 2027
Figure 15: Global Cardiac Resynchronization Therapy Devices Market- By End-User, By Hospitals, By Value (USD Billion), 2017-2027
Figure 16: Global Cardiac Resynchronization Therapy Devices Market- By End-User, By Cardiac Centers, By Value (USD Billion), 2017-2027
Figure 17: Global Cardiac Resynchronization Therapy Devices Market- By End-User, By Research & Laboratories, By Value (USD Billion), 2017-2027
Figure 18: Global Cardiac Resynchronization Therapy Devices Market- By Region Market Share, 2021 & 2027
Figure 19: Americas Population (in Millions), 2018-2021
Figure 20: North America Population ages 65 and above (% of total Population), 2017-21
Figure 21: Latin America & Caribbean Population ages 65 and above (% of total Population), 2017-21
Figure 22: Current health expenditure per capita in the U.S. and Canada (current USD), 2020
Figure 23: Prevalence of Cardiovascular Diseases in Americas, (in million), 2015-2019
Figure 24: Americas Diabetes Prevalence, By Country, 2021 (in million)
Figure 25: Prevalence of Heart Failure in the U.S. & Canada (% of the population), 2020
Figure 26: Americas Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 27: Americas Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 28: Americas Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 29: Market Opportunity Chart of Americas Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
Figure 30: Americas Cardiac Resynchronization Therapy Devices Market- By Country Market Share, 2021 & 2027
Figure 31: United States Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 32: United States Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 33: United States Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 34: Canada Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 35: Canada Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 36: Canada Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 37: European Union Population (in Millions), 2018-2021
Figure 38: Population ages 65 and above (% of total Population) in European Countries, 2020
Figure 39: European Union Current health expenditure per capita (current USD), 2015-19
Figure 40: Country wise healthcare expenditure in Europe (% of GDP), 2020
Figure 41: European Union GDP Per Capita, value (USD Billion), 2018-20
Figure 42: Europe Prevalence of Cardiovascular Diseases (in Million), 2015-2019
Figure 43: Europe Diabetes Prevalence, By Country, 2021 (in million)
Figure 44: Europe Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 45: Europe Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 46: Europe Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 47: Market Opportunity Chart of Europe Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
Figure 48: Europe Cardiac Resynchronization Therapy Devices Market- By Country Market Share, 2021 & 2027
Figure 49: Germany Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 50: Germany Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 51: Germany Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 52: United Kingdom Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 53: United Kingdom Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 54: United Kingdom Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 55: France Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 56: France Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 57: France Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 58: Italy Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 59: Italy Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 60: Italy Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 61: Spain Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 62: Spain Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 63: Spain Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 64: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Figure 65: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020
Figure 66: Asia Pacific Current health expenditure per capita (current USD), 2014-18
Figure 67: Asia Pacific, Current health expenditure per capita, by countries (current USD), 2019
Figure 68: East Asia and Pacific Population (in Billion), 2018-2020
Figure 69: Prevalence of Cardiovascular Diseases in Asia Pacific, (in million), 2015-2019
Figure 70: Asia Pacific Diabetes Prevalence, By Country, 2020 (% of Population Age 20 to 79)
Figure 71: Asia Pacific Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 72: Asia Pacific Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 73: Asia Pacific Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 74: Market Opportunity Chart of Europe Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
Figure 75: Asia Pacific Cardiac Resynchronization Therapy Devices Market- By Country Market Share, 2021 & 2027
Figure 76: China Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 77: China Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 78: China Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 79: Japan Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 80: Japan Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 81: Japan Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 82: India Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 83: India Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 84: India Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 85: Middle East and North Africa Population (in Million), 2018-2020
Figure 86: Middle East & North Africa, Current health expenditure per capita (current USD), 2016-19
Figure 87: Prevalence of Cardiovascular Diseases in Middle East & North Africa, (in million), 2015-2019
Figure 88: Middle East & North Africa, Current health expenditure per capita (% of GDP), 2016-19
Figure 89: MEA Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
Figure 90: MEA Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Figure 91: MEA Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
Figure 92: Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market- By Product (Year-2027)
Figure 93: Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market- By End-User (Year-2027)
Figure 94: Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market- By Region (Year-2027)
Figure 95: Global Cardiac Resynchronization Therapy Devices Market Share (%), 2021
Figure 96: Medtronic Annual Sales Revenue, 2018-2022 (USD Million)
Figure 97: Medtronic Net Income, 2018-2022 (USD Million)
Figure 98: Medtronic Sales Revenue, By Business Segment (%), FY2022
Figure 99: Medtronic Sales Revenue, By Geographical Segment (%), FY2022
Figure 100: Boston Scientific Annual Sales Revenue, 2017-2021 (USD Million)
Figure 101: Boston Scientific Net Income, 2017-2021 (USD Million)
Figure 102: Boston Scientific Sales Revenue, By Business Segment (%), FY2021
Figure 103: Boston Scientific Sales Revenue, By Geographical Segment (%), FY2021
Figure 104: Abbott Laboratories Sales Revenue, 2017-2021 (USD Million)
Figure 105: Abbott Laboratories Net Income, 2017-2021 (USD Million)
Figure 106: Abbott Laboratories Sales Revenue, By Business Segment (%), FY2021
Figure 107: Abbott Laboratories Sales Revenue, By Geographical Segment (%), FY2021
Figure 108: MicroPort Scientific Corporation Annual Sales Revenue, 2017-2021 (USD Million)
Figure 109: MicroPort Scientific Corporation Net Income, 2017-2021 (USD Million)
Figure 110: MicroPort Scientific Corporation Sales Revenue, By Business Segment (%), FY2021
Figure 111: MicroPort Scientific Corporation Sales Revenue, By Geographical Segment (%), FY2021
Figure 112: LivaNova PLC Annual Sales Revenue, 2016-2021 (USD Million)
Figure 113: LivaNova PLC Net Income, 2016-2021 (USD Million)
Figure 114: LivaNova PLC, Sales Revenue, By Business Segment (%), FY2021
Figure 115: LivaNova PLC, Sales Revenue, By Geographical Segment (%), FY2021
List of Table
Table A: Prominent Companies Worldwide Unit Sales of CRT Devices in FY 2021

Methodology

Loading
LOADING...